Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile

I. I. Wistuba, K. Sugio, J. Hung, Y. Kishimoto, A. K. Virmani, I. Roa, J. Albores- Saavedra, A. F. Gazdar

Research output: Contribution to journalArticle

139 Citations (Scopus)

Abstract

Although gallbladder carcinoma is one of the most frequent neoplasms in Chile, there is limited information about the molecular changes involved in its pathogenesis. We investigated the incidence of ras gene mutations and loss of heterozygosity (LOH) at the following genes/loci: p53, DCC, rb, 5q 3p, 8p, and 9p. We precisely microdissected 194 relevant areas from paraffin- embedded microslides from 25 gallbladder carcinomas and their accompanying nonneoplastic lesions (which were present in 15 cases) from patients in Chile. The specimens were analyzed by PCR-based assays for LOH, and we designed a RFLP method for ras mutations and immunohistochemistry for p53 protein overexpression. We determined that LOH at p53 (91%), 9p (50%), 8p (44%) and DCC (31%) are frequent events and that LOH at p53, 9p, and DCC are early events, while ras mutations and LOH at 3p, rb, and 5q occurred occasionally. LOH at p53 occurred more frequently and earlier than protein overexpression. The mean number of mutations present in invasive carcinomas was 2.1, and in six cases, LOH at the p53 gene was the sole mutation detected. The same allele was lost in 61 (93%) of 71 nonneoplastic foci as in the corresponding invasive carcinomas for all four mutations studied. The odds of this occurring by chance are ~4 x 10-15. Although clonality cannot be excluded, allelic loss appears to be highly directed, but the mechanism for allele-specific mutations remains to be determined.

Original languageEnglish (US)
Pages (from-to)2511-2515
Number of pages5
JournalCancer Research
Volume55
Issue number12
StatePublished - 1995
Externally publishedYes

Fingerprint

Chile
Loss of Heterozygosity
Gallbladder
Alleles
Carcinoma
Mutation
p53 Genes
ras Genes
Restriction Fragment Length Polymorphisms
Paraffin
Proteins
Immunohistochemistry
Polymerase Chain Reaction
Incidence

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Wistuba, I. I., Sugio, K., Hung, J., Kishimoto, Y., Virmani, A. K., Roa, I., ... Gazdar, A. F. (1995). Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Research, 55(12), 2511-2515.

Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. / Wistuba, I. I.; Sugio, K.; Hung, J.; Kishimoto, Y.; Virmani, A. K.; Roa, I.; Albores- Saavedra, J.; Gazdar, A. F.

In: Cancer Research, Vol. 55, No. 12, 1995, p. 2511-2515.

Research output: Contribution to journalArticle

Wistuba, II, Sugio, K, Hung, J, Kishimoto, Y, Virmani, AK, Roa, I, Albores- Saavedra, J & Gazdar, AF 1995, 'Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile', Cancer Research, vol. 55, no. 12, pp. 2511-2515.
Wistuba II, Sugio K, Hung J, Kishimoto Y, Virmani AK, Roa I et al. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Research. 1995;55(12):2511-2515.
Wistuba, I. I. ; Sugio, K. ; Hung, J. ; Kishimoto, Y. ; Virmani, A. K. ; Roa, I. ; Albores- Saavedra, J. ; Gazdar, A. F. / Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. In: Cancer Research. 1995 ; Vol. 55, No. 12. pp. 2511-2515.
@article{812afde7c3474d31b24ccf72c8200b1e,
title = "Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile",
abstract = "Although gallbladder carcinoma is one of the most frequent neoplasms in Chile, there is limited information about the molecular changes involved in its pathogenesis. We investigated the incidence of ras gene mutations and loss of heterozygosity (LOH) at the following genes/loci: p53, DCC, rb, 5q 3p, 8p, and 9p. We precisely microdissected 194 relevant areas from paraffin- embedded microslides from 25 gallbladder carcinomas and their accompanying nonneoplastic lesions (which were present in 15 cases) from patients in Chile. The specimens were analyzed by PCR-based assays for LOH, and we designed a RFLP method for ras mutations and immunohistochemistry for p53 protein overexpression. We determined that LOH at p53 (91{\%}), 9p (50{\%}), 8p (44{\%}) and DCC (31{\%}) are frequent events and that LOH at p53, 9p, and DCC are early events, while ras mutations and LOH at 3p, rb, and 5q occurred occasionally. LOH at p53 occurred more frequently and earlier than protein overexpression. The mean number of mutations present in invasive carcinomas was 2.1, and in six cases, LOH at the p53 gene was the sole mutation detected. The same allele was lost in 61 (93{\%}) of 71 nonneoplastic foci as in the corresponding invasive carcinomas for all four mutations studied. The odds of this occurring by chance are ~4 x 10-15. Although clonality cannot be excluded, allelic loss appears to be highly directed, but the mechanism for allele-specific mutations remains to be determined.",
author = "Wistuba, {I. I.} and K. Sugio and J. Hung and Y. Kishimoto and Virmani, {A. K.} and I. Roa and {Albores- Saavedra}, J. and Gazdar, {A. F.}",
year = "1995",
language = "English (US)",
volume = "55",
pages = "2511--2515",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "12",

}

TY - JOUR

T1 - Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile

AU - Wistuba, I. I.

AU - Sugio, K.

AU - Hung, J.

AU - Kishimoto, Y.

AU - Virmani, A. K.

AU - Roa, I.

AU - Albores- Saavedra, J.

AU - Gazdar, A. F.

PY - 1995

Y1 - 1995

N2 - Although gallbladder carcinoma is one of the most frequent neoplasms in Chile, there is limited information about the molecular changes involved in its pathogenesis. We investigated the incidence of ras gene mutations and loss of heterozygosity (LOH) at the following genes/loci: p53, DCC, rb, 5q 3p, 8p, and 9p. We precisely microdissected 194 relevant areas from paraffin- embedded microslides from 25 gallbladder carcinomas and their accompanying nonneoplastic lesions (which were present in 15 cases) from patients in Chile. The specimens were analyzed by PCR-based assays for LOH, and we designed a RFLP method for ras mutations and immunohistochemistry for p53 protein overexpression. We determined that LOH at p53 (91%), 9p (50%), 8p (44%) and DCC (31%) are frequent events and that LOH at p53, 9p, and DCC are early events, while ras mutations and LOH at 3p, rb, and 5q occurred occasionally. LOH at p53 occurred more frequently and earlier than protein overexpression. The mean number of mutations present in invasive carcinomas was 2.1, and in six cases, LOH at the p53 gene was the sole mutation detected. The same allele was lost in 61 (93%) of 71 nonneoplastic foci as in the corresponding invasive carcinomas for all four mutations studied. The odds of this occurring by chance are ~4 x 10-15. Although clonality cannot be excluded, allelic loss appears to be highly directed, but the mechanism for allele-specific mutations remains to be determined.

AB - Although gallbladder carcinoma is one of the most frequent neoplasms in Chile, there is limited information about the molecular changes involved in its pathogenesis. We investigated the incidence of ras gene mutations and loss of heterozygosity (LOH) at the following genes/loci: p53, DCC, rb, 5q 3p, 8p, and 9p. We precisely microdissected 194 relevant areas from paraffin- embedded microslides from 25 gallbladder carcinomas and their accompanying nonneoplastic lesions (which were present in 15 cases) from patients in Chile. The specimens were analyzed by PCR-based assays for LOH, and we designed a RFLP method for ras mutations and immunohistochemistry for p53 protein overexpression. We determined that LOH at p53 (91%), 9p (50%), 8p (44%) and DCC (31%) are frequent events and that LOH at p53, 9p, and DCC are early events, while ras mutations and LOH at 3p, rb, and 5q occurred occasionally. LOH at p53 occurred more frequently and earlier than protein overexpression. The mean number of mutations present in invasive carcinomas was 2.1, and in six cases, LOH at the p53 gene was the sole mutation detected. The same allele was lost in 61 (93%) of 71 nonneoplastic foci as in the corresponding invasive carcinomas for all four mutations studied. The odds of this occurring by chance are ~4 x 10-15. Although clonality cannot be excluded, allelic loss appears to be highly directed, but the mechanism for allele-specific mutations remains to be determined.

UR - http://www.scopus.com/inward/record.url?scp=0029008121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029008121&partnerID=8YFLogxK

M3 - Article

C2 - 7780959

AN - SCOPUS:0029008121

VL - 55

SP - 2511

EP - 2515

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 12

ER -